Sep 13, 2022 / 07:30PM GMT
Cecilia E. Furlong - Morgan Stanley, Research Division - Equity Analyst
Great. Good afternoon, and thank you again for joining us. Welcome to the, again, second day of the Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, a medical device analyst here at Morgan Stanley. It's my pleasure to have Insulet with us today, CEO, Jim Hollingshead; CFO, Wayde McMillan.
Really quickly, just disclosures, please see morganstanley.com/researchdisclosures. With that, again, thank you both for being here today.
James R. Hollingshead - Insulet Corporation - President, CEO & Director
It's a pleasure. Thanks, Cecilia.
Questions and Answers:
Cecilia E. Furlong - Morgan Stanley, Research Division - Equity AnalystAnd I guess to start, just kind of looking at how you're thinking about the business. You had an experience, I think, and would love to kind of hear your perspective, taking in what's traditionally viewed DME type of product and really layering in a lot more of technical component software, either
Trustpilot
